Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-09

FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc. This action typically updates labeling or adds a new indication unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)